AUG 08, 2016 01:18 PM PDT

Mega-complex Discovery Enhances Understanding of Cell Signaling

WRITTEN BY: Carmen Leitch
In the study of cell signaling, one well established paradigm is that receptors on the surface of cells receive input from chemicals outside the cell such as neurotransmitters, drugs, hormones, or foreign invaders, to name but a few, that initiate a signaling cascade. Research conducted at Duke Health has now described a new model of signal activation.
After a G protein receptor is taken back into the cell, it can apparently continue to signal from the cellular compartment. / Credit: Cell Thomsen et al
It’s accepted that G protein coupled receptors (GPCRs) start the signaling sequence in cells after they bind to their ligand. That ligand causes a conformational change in the receptor that in turn activates the attached G protein, causing myriad downstream effects. That process is followed by a desensitization that halts activation and returns the cell to a normal state.

The desensitization is orchestrated by beta-arrestin, a protein that blocks additional activation of the GPCR by binding the receptor and pulling it into the cell in an endocytic process. 

More in-depth study of this process has revealed however, that things are more complex than realized. Researchers have determined that some GPCRs keep signalling to G proteins even after beta-arrestin is on the move and the receptors were enveloped in cellular compartments called endosomes.

Research published in Cell and led by Robert Lefkowitz, M.D., a Howard Hughes Medical Institute investigator who shared in the 2012 Nobel Prize in Chemistry for work on cell signaling, has described new information about the GPCR mechanism.

Scientists led by Lefkowitz characterize the existence, architecture, and functionality of super structures of receptors, which they have termed "mega-plexes" by using a range of biochemical and biophysical techniques.

These mega-plexes are apparently different from the usual couplings of receptors with beta-arrestin; G protein and beta-arrestin are simultaneously bound by using different regions of the receptor. Beta-arrestin only interacts with the receptor tail and leaves the entire inner surface of the receptor exposed which enables the receptor to continue activating the G protein.
Schematic presentation of the biochemical steps in G protein activation in the megaplex: (1) heterotrimeric G protein is recruited to the GPCR-?arr
"The formation of such mega-plexes explains how G proteins can continue to send signals after being internalized by GPCRs," Lefkowitz said. "This opens a whole world of possibilities yet to be explored to manipulate this duality of signaling from outside and inside the cell for therapeutic benefit."
Alex R. B. Thomsen, a co-first author of the study, said some previous reports showed that cells respond differently to G protein signaling from different cellular compartments.

"As a result, pharmaceutical drugs developed in the future, if they are capable of regulating signaling at specific compartments, might be able to better treat certain diseases while having fewer side effects," Thomsen explained. He added, however, that clinical applications of this research are years away.

Sources: AAAS/Eurekalert! via Duke Health, Cell
 
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 24, 2018
Neuroscience
OCT 24, 2018
Self-Restraint And Will Power Improves Weight-Loss: Scientific Evidence
Weight loss success linked with active self-control regions of the brain...
NOV 03, 2018
Cell & Molecular Biology
NOV 03, 2018
New Insight Into the Regulation of Sleep
Once thought of as supporting structures, researchers are uncovering more roles for astrocytes, a type of cell in the brain with a shape like a star....
NOV 16, 2018
Genetics & Genomics
NOV 16, 2018
Using Light to Control Organ Development
Optogenetics combined genetic engineering with optics to create a way to control cellular behaviors with light....
NOV 28, 2018
Immunology
NOV 28, 2018
A Rewind on Autoimmunity
Enzymes identified that are responsible for methylation that will play a role in the production of immune cytokine molecules...
DEC 04, 2018
Genetics & Genomics
DEC 04, 2018
The All-you-can-eat Gene?
Many people dream of being able to eat the foods they want without having to worry about weight gain. New research shows it may one day be possible....
DEC 05, 2018
Videos
DEC 05, 2018
Promising Results From Early Trials of Gene Therapy for Sickle Cell Anemia
More than 90,000 Americans and millions of people around the world have SCA....
Loading Comments...